Breaking News

Robert Califf's approach to regulation & reliability of rapid Covid-19 tests

 

Pharmalot Ed Silverman

Study raises doubts about rapid Covid tests' reliability in early days after infection

By Matthew Herper

Joe Raedle/Getty Images

The study included the Abbott BinaxNow and Quidel Quickvue rapid antigen tests, both of which are authorized by the FDA.

Read More

Robert Califf is a fervent believer in data. At the FDA, will that be enough?

By Matthew Herper

Manuel Balce Ceneta/AP

He avoids black-and-white thinking and values nuance. But those tendencies might not always serve him well in Washington.

Read More

Opinion: The case for Califf: Don't let politics prevent confirmation of best FDA commissioner candidate

By Jeffrey A. Lieberman

Andrew Harnik/AP

Three senators' "concerns" about Robert Califf show a disturbing lack of understanding of the experience needed to lead the FDA.

Read More

STAT+: Chatbots, surveys, and texts: Telehealth companies cut costs by reimagining the front desk

By Mohana Ravindranath

Adobe

Telehealth companies are automating more of their services as they look to provide care for more patients at a lower cost.

Read More

Wednesday, January 5, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments